Johns Hopkins University

Vaccine Prioritization Dashboard Launches @JohnsHopkins for People with Disabilities

Johns Hopkins tool compares how states prioritize disability community in vaccine rollout; helps disabled people determine when they qualify for shots
18-Feb-2021 10:10 AM EST, by Johns Hopkins University

Newswise — A new Johns Hopkins data tool helps people with disabilities determine when they qualify for the COVID-19 vaccine and compares how different states prioritize the disability community in the vaccine rollout.

Created by researchers, students and advocates who themselves are disabled and have personally experienced how inequitable and inaccessible the pandemic response has been, the COVID-19 Vaccine Prioritization Dashboard launched to not only help the disability community get vaccinated, but also to arm policymakers with data to improve the system.

“There’s been a persistent gap in the pandemic response for the disabled community. It started with testing and we’re seeing it being echoed in the vaccine rollout,” said Bonnielin Swenor, director of the Johns Hopkins Disability Health Research Center. “Being part of that community, we understand that need and want to empower the stakeholders and policymakers with data.”

The university’s Disability Health Research Center created the dashboard in collaboration with the Center for Dignity in Healthcare for People with Disabilities.

The idea was sparked by Johns Hopkins senior Sabrina Epstein. Epstein has a genetic connective tissue disorder called Ehlers-Danlos Syndrome which puts her at increased risk for severe illness from COVID-19. Because EDS is considered a rare disease, it is not listed a high-risk chronic illness for vaccine prioritization, making it difficult for Epstein to determine when she can get vaccinated.

“I was trying to register my grandfather for his vaccine in Texas and I noticed that I already qualified in Texas because of my chronic conditions but in Maryland I don’t qualify yet I’m still waiting,” said Epstein, who is majoring in public health studies. “I realized from my own example that it’s happening to lots of people and there’s so much confusion. We want people to be able to use this tool to identify if they or their family or friends qualify for a vaccine in their state and to advance advocacy efforts.”

The tool will be updated weekly.

Another barrier to vaccines for the disability community is the accessibility of information. Often state websites rely on charts and tables that can be difficult or impossible for people with vision impairments and other disabilities. This new tool was created with accessibility in mind.

“The prioritization schemes aim to reduce infection and mortality but access and accessibility has to also be part of that equation,” Swenor said. “There are certain members of the disability community that as of this moment don’t have access to the information or can’t get to the vaccination sites. The path forward has to include accessibility, or we’re never going to reach equity in the pandemic response, as over a quarter of the population has a disability.” 

The COVID-19 Vaccine Prioritization Dashboard: https://disabilityhealth.jhu.edu/vaccine/

  




Filters close

Showing results

110 of 5647
Released: 17-May-2021 9:40 AM EDT
Comprehensive Mount Sinai Study Shows Direct Evidence That COVID-19 Can Infect Cells in Eye
Mount Sinai Health System

Study Has Implications for Preventive Measures to Slow Spread of Virus

Released: 17-May-2021 9:00 AM EDT
How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET
Newswise

How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET

Released: 17-May-2021 9:00 AM EDT
Severe COVID-19 may be linked to long-haul symptoms
University of Michigan

People who experience very severe COVID-19 illness have a higher prevalence of persistent symptoms, according to a new University of Michigan study.

Released: 17-May-2021 8:55 AM EDT
Confused About the Latest Mask Rules? Read This
Michigan Medicine - University of Michigan

A quick guide to navigating life now that the CDC and many states have said that fully vaccinated people do not need to wear masks in many situations.

access_time Embargo lifts in 2 days
Embargo will expire: 19-May-2021 5:00 PM EDT Released to reporters: 17-May-2021 7:15 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-May-2021 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Virtual Awards Ceremony for Alexander Jane Noble Awards Honorees in Tech and Medicine on May 26, 2021
Released: 17-May-2021 7:05 AM EDT
Virtual Awards Ceremony for Alexander Jane Noble Awards Honorees in Tech and Medicine on May 26, 2021
The Novim Group

2021 Alexandra Jane Noble (AJN) Awards ceremony will be virtual, held May 26. ANJ Awards recognizes science innovators

access_time Embargo lifts in 2 days
Embargo will expire: 20-May-2021 2:00 PM EDT Released to reporters: 17-May-2021 7:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-May-2021 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 15-May-2021 8:05 AM EDT
Rutgers Reports First Instance of COVID-19 Triggering Recurrent Blood Clots in Arms
Rutgers University-New Brunswick

Researchers at Rutgers Robert Wood Johnson Medical School are reporting the first instance of COVID-19 triggering a rare recurrence of potentially serious blood clots in people’s arms.

access_time Embargo lifts in 2 days
Embargo will expire: 20-May-2021 10:00 AM EDT Released to reporters: 14-May-2021 2:40 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-May-2021 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 5647

close
1.22594